QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER
<p><strong>Aim.</strong> To assess the quality of arterial hypertension (HT) pharmacotherapy within the outpatient register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current clinical guidelines.</p><p><strong>Material...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/180 |
id |
doaj-8a9c7eb14bc34ae3a878b332c0657e52 |
---|---|
record_format |
Article |
spelling |
doaj-8a9c7eb14bc34ae3a878b332c0657e522020-11-24T22:11:51ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-0110437838310.1234/1819-6446-2014-4-378-383180QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTERA. V. Zagrebelnyy0S. Yu. Martsevich1M. M. Loukianov2E. A. Pravkina3A. N. Vorobyev4S. S. Yakushin5S. A. Boytsov6Государственный научно-исследовательский центр профилактической медициныГосударственный научно-исследовательский центр профилактической медициныГосударственный научно-исследовательский центр профилактической медициныРязанский государственный медицинский университет им. академика И.П. ПавловаРязанский государственный медицинский университет им. академика И.П. ПавловаРязанский государственный медицинский университет им. академика И.П. ПавловаГосударственный научно-исследовательский центр профилактической медицины<p><strong>Aim.</strong> To assess the quality of arterial hypertension (HT) pharmacotherapy within the outpatient register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current clinical guidelines.</p><p><strong>Material and methods.</strong> Patients with HT without ischemic heart disease, chronic heart failure and atrial fibrillation (n=741) were selected from all patients (n=3690) included into the register. Among concomitant diseases were revealed the following: bronchial asthma and/or chronic obstructive pulmonary disease (COPD) – in 42 (5.7%) patients; obesity – in 93 patients, impaired glucose tolerance – in 9 patients, and diabetes mellitus – 84 patients. Prescription of AHD, their number and class were recorded at every next visit to doctor. Accuracy of AHD choice, compliance with current clinical guidelines, and other considerations were assessed through the example of beta-blockers (BBs).</p><p><strong>Results.</strong> AHD were prescribed to 641 patients, and in 13.5% of patients did not receive any AHD. 49.7% of patients received ACE inhibitors, 38.5% – diuretics, 32.5% – BBs. BBs were prescribed to the third part of patients with diabetes and obesity. Furthermore a quarter patients with COPD and the third part of patients with bronchial asthma received BBs. BBs in combination with thiazide diuretics were prescribed to 12 (41.4%) patients with diabetes mellitus and to 13 (40.6%) patients with obesity.</p><p><strong>Conclusion.</strong> Doctors do not always make AHD choice according to current clinical guidelines. Compliance of AHD choice with current clinical guidelines should be an element of treatment quality assessment.</p>http://www.rpcardio.ru/jour/article/view/180артериальная гипертониярегистроценка качества лечениявыбор антигипертензивного препарата |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. V. Zagrebelnyy S. Yu. Martsevich M. M. Loukianov E. A. Pravkina A. N. Vorobyev S. S. Yakushin S. A. Boytsov |
spellingShingle |
A. V. Zagrebelnyy S. Yu. Martsevich M. M. Loukianov E. A. Pravkina A. N. Vorobyev S. S. Yakushin S. A. Boytsov QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER Racionalʹnaâ Farmakoterapiâ v Kardiologii артериальная гипертония регистр оценка качества лечения выбор антигипертензивного препарата |
author_facet |
A. V. Zagrebelnyy S. Yu. Martsevich M. M. Loukianov E. A. Pravkina A. N. Vorobyev S. S. Yakushin S. A. Boytsov |
author_sort |
A. V. Zagrebelnyy |
title |
QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER |
title_short |
QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER |
title_full |
QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER |
title_fullStr |
QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER |
title_full_unstemmed |
QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER |
title_sort |
quality assessment of antihypertensive therapy in patients with arterial hypertension without concomitant cardiovascular diseases as a part of outpatient recvasa register |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-09-01 |
description |
<p><strong>Aim.</strong> To assess the quality of arterial hypertension (HT) pharmacotherapy within the outpatient register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current clinical guidelines.</p><p><strong>Material and methods.</strong> Patients with HT without ischemic heart disease, chronic heart failure and atrial fibrillation (n=741) were selected from all patients (n=3690) included into the register. Among concomitant diseases were revealed the following: bronchial asthma and/or chronic obstructive pulmonary disease (COPD) – in 42 (5.7%) patients; obesity – in 93 patients, impaired glucose tolerance – in 9 patients, and diabetes mellitus – 84 patients. Prescription of AHD, their number and class were recorded at every next visit to doctor. Accuracy of AHD choice, compliance with current clinical guidelines, and other considerations were assessed through the example of beta-blockers (BBs).</p><p><strong>Results.</strong> AHD were prescribed to 641 patients, and in 13.5% of patients did not receive any AHD. 49.7% of patients received ACE inhibitors, 38.5% – diuretics, 32.5% – BBs. BBs were prescribed to the third part of patients with diabetes and obesity. Furthermore a quarter patients with COPD and the third part of patients with bronchial asthma received BBs. BBs in combination with thiazide diuretics were prescribed to 12 (41.4%) patients with diabetes mellitus and to 13 (40.6%) patients with obesity.</p><p><strong>Conclusion.</strong> Doctors do not always make AHD choice according to current clinical guidelines. Compliance of AHD choice with current clinical guidelines should be an element of treatment quality assessment.</p> |
topic |
артериальная гипертония регистр оценка качества лечения выбор антигипертензивного препарата |
url |
http://www.rpcardio.ru/jour/article/view/180 |
work_keys_str_mv |
AT avzagrebelnyy qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT syumartsevich qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT mmloukianov qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT eapravkina qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT anvorobyev qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT ssyakushin qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister AT saboytsov qualityassessmentofantihypertensivetherapyinpatientswitharterialhypertensionwithoutconcomitantcardiovasculardiseasesasapartofoutpatientrecvasaregister |
_version_ |
1725804035639869440 |